A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis

Cancer Research

Volumn 68, Issue 18, 2008, Pages 7293-7303

  Clasper, Steven ^a   Royston, Daniel ^a   Baban, Dilair ^b   Cao, Yihai ^c   Ewers, Stephan ^d   Butz, Stefan ^d   Vestweber, Dietmar ^d   Jackson, David G ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b MRC Functional Genetics Unit   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

^d MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS ASSOCIATED LEPTIN RECEPTOR; BIGLYCAN; CD200 ANTIGEN; CELL ADHESION MOLECULE; COLLAGEN; CYTOKINE; ENDOGLIN; ENDOTHELIAL SPECIFIC ADHESION MOLECULE; FIBRILLIN; MATRIX PROTEIN; TRANSFORMING GROWTH FACTOR BETA CORECEPTOR ENDOGLIN; UNCLASSIFIED DRUG; VASCULOTROPIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; C57BL 6 MOUSE; CELL ISOLATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOWN REGULATION; ENDOTHELIUM; FEMALE; FIBROSARCOMA; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE INDUCTION; GENETIC CODE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; TIGHT JUNCTION; TUMOR GROWTH; UPREGULATION; VASCULARIZATION;

ANIMALS; CELL ADHESION MOLECULES; CELL GROWTH PROCESSES; ENDOTHELIAL CELLS; FIBROSARCOMA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPH NODES; LYMPHATIC METASTASIS; MICE; MICE, INBRED C57BL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, LEPTIN; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 54749126267     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-6506     Document Type: Article

References (54)

1. Achen M, Mann GB, Stacker S. Targeting lymphangiogenesis to prevent tumour metastasis. Br J Cancer 2006;94:1355-60.
2. Witte MH, Jones K, Wilting J, et al. Structure-function relationships in the lymphatic system and implications for cancer biology. Cancer Metastasis Rev 2006;25:159-84.
3. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007;7:678-89.
4. Shields J, Emmett MS, Dunn DBA, et al. Chemokine-mediated migration of melanoma cells towards lymphatics - a mechanism contributing to metastasis. Oncogene 2006;26:2997-3005.
5. Beasley NJ, Prevo R, Banerji S, et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 2002;62:1315-20.
6. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002;2:573-83.
7. Skobe M, Hawighorst T, Jackson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7:192-8.
8. Mandriota SJ, Jussila L, Jeltsch M, et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001;20:672-82.
9. Stacker SA, Caesar C, Baldwin ME, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001;7:186-91.
10. Hoshida T, Isaka N, Hagendoorn J, et al. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 2006;66:8065-75.
11. Zhang L, Giraudo E, Hoffman JA, Hanahan D, Ruoslahti E. Lymphatic zip codes in premalignant lesions and tumors. Cancer Res 2006;66:5696-706.
12. Breslin JW, Gaudreault N, Watson KD, Reynoso R, Yuan S, Wu, MH. Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism. Am J Physiol Heart Circ Physiol 2007;293:709-18.
13. Eichten A, Hyun WC, Coussens LM. Distinctive features of angiogenesis and lymphangiogenesis determine their functionality during de novo tumor development. Cancer Res 2007;67:5211-20.
14. St Croix B, Rago C, Velculescu V, et al. Genes expressed in human tumor endothelium. Science 2000;289:1197-202.
15. Nanda A, Buckhaults P, Seaman S, et al. Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R. Cancer Res 2004;64:8507-11.
16. Nanda A, Carson-Walter EB, Seaman S, et al. TEM8 interacts with the cleaved C5 domain of collagen a 3(VI). Cancer Res 2004;64:817-20.
17. Seaman S, Stevens J, Yang MY, Logsdon D, Graff-Cherry C, St. Croix B. Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 2007;11:539-54.
18. Cao R, Bjorndahl MA, Religa P, et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 2004;6:333-45.
19. Johnson LA, Clasper S, Holt A, Lalor P, Baban D, Jackson DG. An inflammation-induced mechanism for leukocyte transmigration of lymphatic endothelium. J Exp Med 2006;203:2763-77.
20. Wegmann F, Petri B, Khandoga AG, et al. ESAM supports neutrophil extavsation, activation of Rho, and VEGF-induced vascular permeability. J Exp Med 2006;203:1671-7.
21. Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME) - towards standards for microarray data. Nat Genet 2001;29:365-71.
22. Bolstad BM, Irizarry RA, Astrand M, Speed TPA. Comparison of normalization methods for high density oligonucleotide array data based on bias and variance. Bioinformatics 2003;19:185-93.
23. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249-64.
24. Wang X, Seed B. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 2003;31:e154.
25. Johnson LA, Prevo R, Clasper S, Jackson DG. Inflammation-induced uptake and degradation of the lymphatic endothelial hyaluronan receptor LYVE-1. J Biol Chem 2007;282:33671-80.
26. Cera MR, Del Prete A, Vecchi A, et al. Increased DC trafficking to lymph nodes and contact hypersensitivity in junctional adhesion molecule-A-deficient mice. J Clin Invest 2004;114:729-38.
27. Zen K, Liu Y, McCall IC, et al. Neutrophil migration across tight junctions is mediated by adhesive interactions between epithelial coxsackie and adenovirus receptor and a junctional adhesion molecule-like protein on neutrophils. Mol Biol Cell 2005;16:2694-703.
28. Nathan C, Muller WA. Putting the brakes on innate immunity: a regulatory role for CD200? Nat Immunol 2001;2:17-9.
29. Schonherr E, Witsch-Prehm P, Harrach B, Robenek H, Rauterberg J, Kresse H. Interaction of biglycan with type I collagen. J Biol Chem 1995;270:2776-83.
30. Isogai Z, Ono RN, Ushiro S, et al. Latent transforming growth factor β-binding protein 1 interacts with fibrillin and is a microfibril- associated protein. J Biol Chem 2003;278:2750-7.
31. Tanaka K, Hiraiwa N, Hashimoto H, Yamazaki Y, Kusakabe M. Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression. Int J Cancer 2004;108:31-40.
32. Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A 2001;98:6390-5.
33. Lebrin F, Deckers M, Bertolino P, Ten Dijke P. TGF-β receptor function in the endothelium. Cardiovasc Res 2005;65:599-608.
34. Gale NW, Thurston G, Hackett SF, et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Dev Cell 2002;3:411-23.
35. Finegold DN, Kimak MA, Lawrence EC, et al. Truncating mutations in FOXC2 cause multiple lymphedema syndromes. Hum Mol Genet 2001;10:1185-9.
36. Abtahian F, Guerriero A, Sebzda E, et al. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 2003;299:247-51.
37. Matloubian M, Lo CG, Cinamon G, et al. Nature 2004;427:355-60.
38. Ledgerwood LG, Lal G, Zhang N, et al. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat Immunol 2007;9:42-53.
39. Schacht V, Ramirez MI, Hong YK, et al. T1 α/ podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J 2003;22:3546-56.
40. Yong C, Bridenbaugh EA, Zawieja D, Swartz MA. Microarray analysis of VEGF-C responsive genes in human lymphatic endothelial cells. Lymphat Res Biol 2005;3:183-207.
41. Maula SM, Luukkaa M, Grenman R, Jackson D, Jalkanen S, Ristamaki R. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 2003;63:1920-6.
42. Hirata K, Ishida T, Penta K, et al. Cloning of an immunoglobulin family adhesion molecule selectively expressed by endothelial cells. J Biol Chem 2001;276:16223-31.
43. Ishida T, Kundu RK, Yang E, Hirata K, Ho YD, Quertermous T. Targeted disruption of endothelial cell-selective adhesion molecule inhibits angiogenic processes in vitro and in vivo. J Biol Chem 2003;278:34598-604.
44. Podgrabinska S, Braun P, Velasco P, et al. Molecular characterization of lymphatic endothelial cells. Proc Natl Acad Sci USA 2002;99:16069-74.
45. Hirakawa S, Hong YK, Harvey N, et al. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol 2003;162:575-86.
46. Karpanen T, Wirzenius M, Makinen T, et al. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am J Pathol 2006;169:708-18.
47. Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler K, St Croix B. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 2001;61:6649-55.
48. Ebnet K, Suzuki A, Ohno S, Vestweber D. Junctional adhesion molecules ( JAMs): more molecules with dual functions? J Cell Sci 2004;117:19-29.
49. Li DY, Sorensen LK, Brooke BS, et al. Defective angiogenesis in mice lacking Endoglin. Science 1999;284:1534-7.
50. Fonsatti E, Maio M. Highlights on Endoglin (CD105): from basic findings towards clinical applications in human cancer. J Transl Med 2004;2:18-24.
51. Nathanson SD, Zarbo RJ, Wachna DL, Spence CA, Andrzejewski TA, Abrams J. Microvessels that predict axillary lymph node metastases in patients with breast cancer. Arch Surg 2000;135:586-93.
52. Bono P, Wasenius V, Lundin J, Jackson DG, Joensuu H. High peritumoral LYVE-1 positive lymphatic vessel numbers are associated with axillary lymph node metastases and poor outcome in early breast cancer. Clin Cancer Res 2004;10:7144-9.
53. Shields JD, Borsetti M, Rigby H, et al. Lymphatic density and metastatic spread in human malignant melanoma. Br J Cancer 2004;90:693-700.
54. Von Marschall Z, Scholz A, Stacker S, et al. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. Int J Oncol 2005;27:669-79.